CLINICAL_TRIALS
research
· 2026-03-31
Clinical Trial Update: A Study of TCD601 (Siplizumab) in Newly Diagnosed Adult Amyotrophic Lateral Sclerosis (ALS) Patients [Phase 1]
Summary
Phase 1 trial update for TCD601 (Siplizumab) in newly diagnosed adult amyotrophic lateral sclerosis patients; recruitment is ongoing.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ITB-Med LLC | Conditions: ALS | Phase 1 | Status: RECRUITING